logo

For the Inventor, By the Inventor

Durham, NC, United States of America

Viamet Pharmaceuticals, Inc.


USPTO Granted Patents = 23

% Expired Patents = 47.8



Forward Citations = 442

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal William Joel Hoekstra (23 out of 81 patents)

silverMedal Robert J Schotzinger (17 out of 23 patents)

bronzeMedal Stephen William Rafferty (12 out of 18 patents)

4.  Christopher M Yates (11 out of 46 patents)

5.  Michael R Loso (8 out of 38 patents)

6.  Michael Thomas Sullenberger (8 out of 29 patents)

7.  Gary David Gustafson (6 out of 21 patents)

8.  Zachary A Buchan (4 out of 17 patents)

9.  Thierry Bonnaud (1 out of 14 patents)

10.  Tracy Ehiwe (1 out of 6 patents)

11.  Daniel Knueppel (1 out of 34 patents)

12.  David Dale Wirth (1 out of 30 patents)

13.  Javier Delgado (4 patents)

14.  Xuelin Wang (1 patent)

15.  Asaf Alimardanov (15 patents)


23 patents:

1. 9840492 - Antifungal compounds and processes for making (2017-12-12),
2. 9802914 - Antifungal compound process (2017-10-31),
3. 9688671 - Metalloenzyme inhibitor compounds (2017-06-27),
4. 9663488 - Metalloenzyme inhibitor compounds (2017-05-30),
5. 9556143 - Metalloenzyme inhibitor compounds (2017-01-31),
6. 9447073 - Fungicidal compositions (2016-09-20),
7. 9414596 - Metalloenzyme inhibitor compounds (2016-08-16),
8. 9309273 - Metalloenzyme inhibitor compounds (2016-04-12),
9. 9221791 - Metalloenzyme inhibitor compounds (2015-12-29),
10. 9220265 - Metalloenzyme inhibitor compounds (2015-12-29),
11. 9056855 - Metalloenzyme inhibitor compounds (2015-06-16),
12. 8940735 - Metalloenzyme inhibitor compounds (2015-01-27),
13. 8901121 - Metalloenzyme inhibitor compounds (2014-12-02),
14. 8883797 - Metalloenzyme inhibitor compounds (2014-11-11),
15. 8809378 - Metalloenzyme inhibitor compounds (2014-08-19),
Company Overview
Viamet Pharmaceuticals, Inc. is a biopharmaceutical company based in Durham, North Carolina, focused on the discovery and development of innovative therapies for serious diseases. The company specializes in the development of novel antifungal and antiviral agents, leveraging its proprietary technology platforms to create targeted treatments. Viamet's research is centered on addressing unmet medical needs in infectious diseases, with a commitment to advancing healthcare through scientific innovation.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

23 Patents

#40 in Durham, NC

#334 in North Carolina

#14,415 in US

#27,649 in the World

Durham, NC (US)
Durham, NC, United States of America

Viamet Pharmaceuticals, Inc.

Forward Citations = 442

12 inventors:

goldMedal William Joel Hoekstra (23 out of 81 patents)

silverMedal Robert J Schotzinger (17 out of 23 patents)

bronzeMedal Stephen William Rafferty (12 out of 18 patents)

4.  Christopher M Yates (11 out of 46 patents)

5.  Michael R Loso (8 out of 38 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Viamet Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/viamet-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Please report any incorrect information to [email protected]
Loading…